InnerWorkings Inc. (INWK) Jumps 7.04% on February 19

Equities Staff |

InnerWorkings Inc. (INWK) was among the biggest gainers on the Russell 2000 for Friday February 19 as the stock popped 7.04% to $6.99, representing a gain of $0.46 per share. Some 236,914 shares traded hands on 1,934 trades, compared with an average daily volume of 150,774 shares out of a total float of 53.91 million. The stock opened at $6.95 and traded with an intraday range of $7.36 to $6.78.

After today's gains, InnerWorkings Inc. reached a market cap of $376.82 million. InnerWorkings Inc. has had a trading range between $8.69 and $5.95 over the last year, and it had a 50-day SMA of $7.10 and a 200-day SMA of $7.05.

The stock has a P/E Ratio of 7.9.

InnerWorkings Inc is a marketing supply chain company that provides print management and promotional solutions to corporate clients across various industries.

InnerWorkings Inc. is based out of Chicago, IL and has some 1,600 employees. Its CEO is Eric D. Belcher.

For a complete fundamental analysis analysis of InnerWorkings Inc., check out’s Stock Valuation Analysis report for INWK. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…